Loading...
Abemaciclib: a CDK4/6 inhibitor for the treatment of HR+/HER2− advanced breast cancer
Although early breast cancer (BC) is highly curable, advanced or metastatic disease poses numerous challenges in terms of medical management and treatment decisions and is associated with significantly worse prognosis. Among the new targeted agents, anticancer drugs exploiting the cell-cycle machine...
Saved in:
| Published in: | Drug Des Devel Ther |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Dove Medical Press
2018
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5818877/ https://ncbi.nlm.nih.gov/pubmed/29497278 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S137783 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|